1. Home
  2. XERS vs ULH Comparison

XERS vs ULH Comparison

Compare XERS & ULH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XERS
  • ULH
  • Stock Information
  • Founded
  • XERS 2005
  • ULH 1932
  • Country
  • XERS United States
  • ULH United States
  • Employees
  • XERS N/A
  • ULH N/A
  • Industry
  • XERS Biotechnology: Pharmaceutical Preparations
  • ULH Trucking Freight/Courier Services
  • Sector
  • XERS Health Care
  • ULH Industrials
  • Exchange
  • XERS Nasdaq
  • ULH Nasdaq
  • Market Cap
  • XERS 628.7M
  • ULH 709.5M
  • IPO Year
  • XERS 2018
  • ULH 2005
  • Fundamental
  • Price
  • XERS $5.01
  • ULH $23.31
  • Analyst Decision
  • XERS Strong Buy
  • ULH Hold
  • Analyst Count
  • XERS 6
  • ULH 1
  • Target Price
  • XERS $6.25
  • ULH $29.00
  • AVG Volume (30 Days)
  • XERS 2.2M
  • ULH 71.7K
  • Earning Date
  • XERS 05-08-2025
  • ULH 04-24-2025
  • Dividend Yield
  • XERS N/A
  • ULH 1.80%
  • EPS Growth
  • XERS N/A
  • ULH N/A
  • EPS
  • XERS N/A
  • ULH 3.17
  • Revenue
  • XERS $222,551,000.00
  • ULH $1,736,518,000.00
  • Revenue This Year
  • XERS $31.75
  • ULH N/A
  • Revenue Next Year
  • XERS $21.09
  • ULH $7.92
  • P/E Ratio
  • XERS N/A
  • ULH $7.34
  • Revenue Growth
  • XERS 29.88
  • ULH 1.16
  • 52 Week Low
  • XERS $1.72
  • ULH $20.60
  • 52 Week High
  • XERS $6.07
  • ULH $53.29
  • Technical
  • Relative Strength Index (RSI)
  • XERS 59.63
  • ULH 43.32
  • Support Level
  • XERS $4.26
  • ULH $21.65
  • Resistance Level
  • XERS $5.28
  • ULH $23.48
  • Average True Range (ATR)
  • XERS 0.28
  • ULH 1.37
  • MACD
  • XERS 0.09
  • ULH -0.01
  • Stochastic Oscillator
  • XERS 78.91
  • ULH 36.75

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

About ULH Universal Logistics Holdings Inc.

Universal Logistics Holdings Inc is an asset-light provider of customized transportation and logistics solutions throughout the United States, and in Mexico, Canada and Colombia. It offers services such as truckload, brokerage, intermodal, dedicated, and value-added services. The company reports into four segments namely trucking, intermodal, company-managed brokerage, and contract logistics. The majority of the revenue is earned from the contract logistics segment.

Share on Social Networks: